ID HBC-4 AC CVCL_B496 SY HBC4 DR EFO; EFO_0022354 DR Cosmic; 1436028 DR IARC_TP53; 21643 DR Wikidata; Q54881371 RX PubMed=8882729; RX PubMed=15767549; RX PubMed=15900046; RX PubMed=22336246; CC Part of: JFCR39 cancer cell line panel. CC Part of: JFCR45 cancer cell line panel. CC Population: Japanese. CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=15900046). CC Omics: Transcriptomics; Microarray. CC Derived from site: In situ; Breast; UBERON=UBERON_0000310. DI NCIt; C4872; Breast carcinoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Female AG 72Y CA Cancer cell line DT Created: 06-06-12; Last updated: 10-04-25; Version: 19 // RX PubMed=8882729; DOI=10.1093/oxfordjournals.jbchem.a021246; RA Satoh, Ayano RA Takayama, Eiji RA Kojima, Kiyoko RA Ogawa, Haruko RA Yamori, Takao RA Sato, Shigeo RA Kawaguchi, Tokuichi RA Tsuruo, Takashi RA Katsura, Yoshimoto RA Kina, Tatsuo RA Matsumoto, Isamu RT "Expression of carbohydrate-binding protein p33/41 in human tumor cell RT lines."; RL J. Biochem. 119:346-353(1996). // RX PubMed=15767549; DOI=10.1158/1535-7163.MCT-04-0234; RA Nakatsu, Noriyuki RA Yoshida, Yoko RA Yamazaki, Kanami RA Nakamura, Tomoki RA Dan, Shingo RA Fukui, Yasuhisa RA Yamori, Takao RT "Chemosensitivity profile of cancer cell lines and identification of RT genes determining chemosensitivity by an integrated bioinformatical RT approach using cDNA arrays."; RL Mol. Cancer Ther. 4:399-412(2005). // RX PubMed=22336246; DOI=10.1016/j.bmc.2012.01.017; RA Kong, De-Xin RA Yamori, Takao RT "JFCR39, a panel of 39 human cancer cell lines, and its application in RT the discovery and development of anticancer drugs."; RL Bioorg. Med. Chem. 20:1947-1951(2012). // RX PubMed=15900046; DOI=10.1093/jnci/dji133; RA Mashima, Tetsuo RA Oh-hara, Tomoko RA Sato, Shigeo RA Mochizuki, Mikiko RA Sugimoto, Yoshikazu RA Yamazaki, Kanami RA Hamada, Jun-ichi RA Tada, Mitsuhiro RA Moriuchi, Tetsuya RA Ishikawa, Yuichi RA Kato, Yo RA Tomoda, Hiroshi RA Yamori, Takao RA Tsuruo, Takashi RT "p53-defective tumors with a functional apoptosome-mediated pathway: a RT new therapeutic target."; RL J. Natl. Cancer Inst. 97:765-777(2005). //